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Abstract 
 Introduction :The overexpression of p16INK4a is considered to be 
strong and consistent in HPV-induced cancers. The objective of this study 
was to investigate the presence of HPV DNA in cervical biopsies, and to 
study the overexpression of p16INK4a as a marker of precancerous and 
cancerous lesions of the cervix.  
Material and methods :A total of 75 cervical biopsies were included in this 
study involving cervicitis (n = 11), mild dysplasia (n = 17), severe dysplasia 
(n = 30) and invasive carcinomas (n = 17). The presence of HPV was 
assessed using an examination in situ hybridization (CSA). p16INK4a protein 
expression was investigated by immunohistochemistry. 
Results: p16INK4a expression was very low in benign cervical lesions, while 
18.8% of these lesions showed positivity for HPV DNA detection. Forty 
seven percent of mild dysplastic lesions presented overexpression of p16INK4a 
protein, and 76.4% were HPV positive. Strong signal of p16INK4a was 
observed in 100% of severe dysplastic lesions, and in 94.2% of invasive 
carcinoma. HPV DNA was detected in 83.3% of severe dysplastic lesions, 
and in 82.3% of invasive carcinoma. 
European Scientific Journal October 2015 edition vol.11, No.30 ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
 
113 
Conclusion: This pattern of overexpression demonstrates the potential use of 
p16INK4a as a diagnostic marker to recognize evolution of precancerous 
disease in the cervix.  
 
Keywords: P16INK4a protein- Cervical cancer- Immunohistochemistry-HPV-         
In situ hybridization (CSA). 
 
Introduction 
 Human papillomaviruses (HPV) are known to be a major causative 
agent in cervical neoplasia and invasive cervical carcinoma. HPVs have 
circular, double-stranded DNA genomes that are approximately 8 kb in size 
and encode eight genes, of which E6 and E7 have transforming properties. 
The ability of high-risk HPV E7 protein to associate with the tumor 
suppressors pRB has been suggested as a mechanism by which this viral 
protein induce tumor (Crook, Tidy et al. 1991). p16INK4a is a cyclin-
dependent kinase inhibitor that regulates the activity of cyclin-dependent 
kinases 4 and 6. When the HPV E7 oncoprotein inactivates 
retinoblastoma, p16 expression increases dramatically (Phelps, Yee et al. 
1988; Dyson, Howley et al. 1989; Koh, Enders et al. 1995; Jedpiyawongse, 
Homcha-em et al. 2008). p16INK4a overexpression in some types of tumors, 
such as cervical cancer, is used as a diagnostic tool and has been directly 
associated with infection by high risk (HR) HPV genotypes (Masumoto, 
Fujii et al. 2003; Mulvany, Allen et al. 2008). The aim of this study was to 
investigate the presence of HPV DNA in cervical biopsies, and to study the 
overexpression of p16INK4a as a biomarker of precancerous and cancerous 
lesions on biopsy specimens of the uterine cervix due to abnormal 
cytological finding. 
 
Material and methods 
 Seventy five cervical biopsies were included in the study; they were 
identified in the laboratory of histo-cytopathology of Institut Pasteur du 
Maroc. The samples were fixed in 10% formalin and embedded in paraffin. 
Sections of 3-4 microns paraffin were placed on silanized slides. Initially, the 
samples were subjected to histopathological study by hematoxylin-eosin 
conventional technique (H&E). Secondly, immunohistochemistry was 
performed to assess the expressions of p16INK4a protein, we used the protocol 
of CINtec Histology Kit (Biogen/Roche, Germany), according to the 
manufacturer’s protocol. The samples were incubated overnight at 37 ° C, 
then at 60 ° C for 30 minutes, after which they were dewaxed in three 
successive baths of xylene (15 minutes for each bath). This was followed by 
rehydration through successive passage of the sections through four alcohol 
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baths with decreasing concentrations (100% alcohol, 90% alcohol, 80% 
alcohol, 70% alcohol), for approximately 10 minutes per each bath. 
 After incubation with primary mouse monoclonal antibody against 
human p16INK4a protein (clone designation E6H4), visualization is based on a 
dextran technology. The reagent consists of both molecules secondary 
immunoglobulin and goat anti-mouse horseradish peroxidase molecules 
linked to a common dextran polymer support, thereby removing the need for 
sequentially applying binding antibody and peroxidase-conjugated antibody. 
The enzymatic conversion by the chromogen (AEC) results in the formation 
of a visible precipitate at the antigen site. The slides were stained with cons-
Mayer hematoxylin and mounted in aqueous medium. The results were 
evaluated using an optical microscope. The reaction is considered positive 
when the cell shows a brownish color at the nuclear level and / or 
cytoplasmic. The slides were then counterstained with Mayer's hematoxylin 
and mounted in aqueous medium. The results were evaluated using an 
optical microscope. The reaction was considered as positive when the cell 
showed a brownish color at the nuclear level and / or cytoplasmic. The 
immunoreactivity results of anti-p16INK4a antibodies were determined by 
applying a semi-quantitative scale described by Klaes et al. (Klaes, Friedrich 
et al. 2001) : 
• Negative: less than 1% of cells are positive. 
• Sporadic: isolated positive cells, but less than 5%. 
• Focal: small cell clusters, but less than 25% of the positive cells. 
• Diffuse: more than 25% of stained cells. 
 
HPV detection 
 To detect HPV DNA, all cervical biopsies were subjected to in situ 
hybridization with the amplification signal (HIS CSA) using a biotinylated 
probe with broad spectrum. Following dewaxing and hydration, proteolytic 
digestion was performed by proteinase K. The denaturation of probe and 
target DNA was carried out on a hotplate at 95 ° C and transferred to 37 ° C 
for hybridization. The reaction product was revealed using the system 
"GenPoint DAKO," which creates an additional level of amplification of the 
signal, its principle is based on the use of highly sensitive tyramide for the 
detection of biotinylated probes in cell and tissue preparations. Revelation of 
the hybridization signal was produced by a chromogenic indicator, 
diaminobenzidine (DAB), which oxidized by peroxidase gives a brownish 
precipitate at the hybridization site. 
 The slides were counterstained with Mayer's hematoxylin, 
dehydrated and mounted by the Permanent Mounting Medium (DAKO), then 
examined by light microscope. 
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Results 
Histopathological examination 
 The histopathological diagnosis of the 75 studied biopsies revealed: 
11 cervicitis, 17 mild dysplasia, 30 severe dysplasia and 17 invasive cancers 
(Table 1). 
Table 1: Lesions diagnosed by histopathology 
Lesions Number % 
Cervicitis 11 17 
Mild dysplasia 17 26 
Severe dysplasia 30 31 
Invasive carcinoma 17 26 
Total 75 100 
 
Immunohistochemical examination 
 As shown in Table 2, all cases of cervicitis were  negative with 
immunostaining of p16INK4a protein, 47% of mild dysplasia were positive 
while severe dysplasias and invasive carcinomas showed overexpression of 
p16INK4a in 100% and 94.2% of cases respectively. 
Table 2: Results of Immunolabeling protein p16INK4a 
Lesions Negative p16INK4a 
protein 
Positive p16INK4a 
protein 
cervicitis  (n=11) 
mild dysplasia (n=17) 
severe dysplasia (n=30) 
invasive carcinoma (n=17) 
11  (100%) 
9  (53%) 
0 
1 (5,8%) 
0 
8   (47%) 
30  (100%) 
16    (94,2) 
 
 Immunoreactivity results of the anti-p16INK4a antibodies were 
determined by the implementation of a semi quantitative scale and were 
showed in Figures 1, 2, 3 and 4. Thus, in our series, immunostaining of the 
p16INK4a protein was sporadic, focal and diffuse in 10%, 70% and 20% of 
mild dysplasia respectively. Focal and diffuse immunostaining were 
observed in 44% and 66% of severe dysplasia, respectively. While in 
invasive cancers, immunostaining was focal in 17% of cases and diffuse in 
83% of cases (Table 3). 
Table 3: Immunolabelling type of overexpression of p16INK4a protein 
Lesions Sporadic (%) Focal (%) Diffuse (%) 
Mild dysplasia (n=8) 
Severe dysplasia (n=30) 
Invasive carcinoma (n=16) 
10 
0 
0 
70 
44 
17 
20 
66 
83 
 
Overexpression of p16INK4a protein and detection of HPV 
 To determine the relation between the overexpression of p16INK4a 
protein and the presence of HPV in cervical lesions, we performed a 
detection of HPV by HIS (CSA) using a probe with broad spectrum for all 
biopsies; the results were reported in Table 4. In the cervicitis group, none of 
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the cases showed p16INK4a protein overexpression, whereas 18.2% (2/17) of 
these lesions showed positivity for HPV detection. Forty seven percent 
(8/17) of mild dysplasia were positive for the overexpression of p16INK4a 
protein and 76.4% (13/17) were HPV positive. In severe dysplasia and 
invasive cancer, a positive reaction for the p16INK4a protein immunostaining 
was observed in 100% (30/30) and 94.2% (16/17) of cases, respectively, 
while HPV was detected in 83.3% (25/30) of severe dysplasia and 82.3% 
(14/17) of cases of cancer. 
Table 4: Results of the overexpression of p16INK4a protein and HPV detection 
Lesions Proteine p16
INK4a HPV (Detection) 
Positive Negative Positive Negative 
cervicitis (n=11) 
 
mild dysplasia (n =17) 
 
severe dysplasia (n= 30) 
 
invasive carcinoma (n= 
17) 
0 
 
8 (47%) 
 
 
30 (100%) 
 
 
16 (94,2%) 
11 (11%) 
 
9 (53%) 
 
 
0 
 
 
1 (5,8%) 
2 (18,2%) 
 
13 (76,4%) 
 
 
25 (83,3%) 
 
 
14 (82,3%) 
9 (81,8%) 
 
4 (23,6%) 
 
 
5 (16,7%) 
 
 
3 (17,7%) 
 
             
 
 
 
 
A B 
Figure 1:  Overexpression of p16INK4a protein in cervical Biopsy (G x 40), negative control. 
A: Mild dysplasia 
B: Invasive cancer 
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C 
Figure 2: Positive overexpression of the protein p16INK4a: Mild dysplasia. 
A: Sporadic Immunolabeling (G x 20) 
B: Focal Immunolabeling (G x 40) 
C: Immunolabeling diffuse (G x 20) 
  
A B 
Figure3: Positive overexpression of the protein p16INK4a : severe dysplasia. 
A: Focal Immunolabeling (G x 40) 
B: Immunostaining diffuse (G x 20) 
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A B 
Figure 4: : Diffuse immunostaining of the protein p16INK4a: Invasive cancer 
(A: G x 20), (B: G x 40) 
 
 
Discussion 
 The causal role of persistent infection with HPV oncogene in the 
development of cervical cancer has been confirmed (Walboomers, Jacobs et 
al. 1999; Bosch, Lorincz et al. 2002; Munoz, Bosch et al. 2003). Strong 
overexpression of p16INK4a has been reported in various uterine tumors, 
particularly in cervical cancer associated with infection by an HPV oncogene 
(Sano, Oyama et al. 1998; Agoff, Lin et al. 2003; Negri, Vittadello et al. 
2004). Due to the association between p16INK4a protein overexpression and 
the presence of intraepithelial neoplasia, many studies have assessed the 
benefit of p16INK4a protein detection by immunohistochemistry in the 
diagnosis of histological and cytological specimens of the cervix (Klaes, 
Benner et al. 2002; Bergeron, Wentzensen et al. 2006). The aim of this study 
was to investigate the presence of HPV DNA in cervical biopsies, and to 
study the overexpression of p16INK4a as a biomarker of precancerous and 
cancerous lesions on biopsy specimens of the uterine cervix. 
 In our series, all cases of cervicitis were negative with 
immunostaining of p16INK4a protein, 47% of mild dysplasia were positive, 
while severe dysplasia and invasive cancers showed overexpression of 
p16INK4a protein in 100% and 94.2% of cases respectively. The results of the 
immunoreactivity of anti-p16INK4a antibody were determined by the 
application of a semi quantitative scale described by Klaes et al. (Klaes, 
Friedrich et al. 2001). These results were similar to those reported in many 
studies, where nearly 100% of high grade lesions and invasive cancers 
showed a strong overexpression of p16INK4a protein, while non-dysplastic 
lesions remained negative (Calil, Edelweiss et al. 2014). In a Spanish study, 
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91.7% of invasive cervical cancers showed a positive overexpression of 
p16INK4a protein with a diffuse immunostaining (Perez, Castillo et al. 2014). 
Agoff et al. reported in his study that 91% of cervical cancers with 
overexpression of p16INK4a protein were associated with infection by 
oncogenic HPV, which allowed him to deduce that p16INK4a protein might be 
a potential marker of cervical neoplasia screening (Agoff, Lin et al. 2003). 
 Our findings showed a weak immunostaining in mild dysplasia, 
which were similar to results obtained by Sano et al. and Lesnikova et al.; 
they marked an overexpression of p16INK4a protein in high-grade dysplastic 
lesions and also in invasive cervical cancers, associated with infection by an 
oncogene HPV. However, in genital warts and mild dysplasia 
immunoreaction was low (Sano, Oyama et al. 1998; Lesnikova, Lidang et al. 
2009). Another study, conducted in china, reported that 43.1% of cervical 
cancers were positive for overexpression of p16INK4a protein. 
Immunostaining was found reduced in mild dysplasia (Jin, Zhang et al. 
2000). Contradictory, a large meta-analysis of 15 publications comprised 
1633 cases, showed that p16INK4a overexpression was not significantly 
associated with tumor TNM staging (Lin, Albers et al. 2014).  
 About nineteen percent of cervicitis cases showed positivity of HPV. 
For mild dysplasia, 76.4% were HPV positive. For severe dysplasia and 
invasive cancers, the HPV was detected in 83.3% and 82.3% of cases 
respectively. During an infection by an oncogene HPV, p16INK4a protein is 
induced in the basal cells of the cervical squamous epithelium through the 
expression of viral oncogenes E6 and E7. This overexpression is attributed to 
interference between the expression of the viral oncogene E7 that associates 
with the gene product pRb. The pRb gene is usually linked to E2F which 
blocks the activation of the cell cycle by a phosphorylation mechanism. The 
release of E2F-induced link between E7 and pRb gene results in a significant 
negative feedback repression of gene p16INK4a transcription (Narisawa-Saito 
and Kiyono 2009; Yugawa and Kiyono 2009). 
  
Conclusion 
 In total, the overexpression of p16INK4a protein indicates the 
inactivation of cell cycle control mediated by oncogenic HPV oncoproteins. 
At the end of this study, we can conclude that p16INK4a protein could be a 
promising marker for the diagnosis of precancerous and cancerous lesions of 
the cervix; it can highlight a persistent viral infection with an oncogenic 
HPV.  
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